Clinical trial
Paclitaxel and Oxaliplatin in Treating Patients With Recurrent or Advanced…
NCT00004126 · University of Chicago, Other · Completed
Key facts
| NCT number | NCT00004126 |
|---|---|
| Title | Paclitaxel and Oxaliplatin in Treating Patients With Recurrent or Advanced Non-small Cell Lung Cancer |
| Official title | A Phase II Study of Oxaliplatin in Combination With Paclitaxel in Non-Small Cell Lung Cancer |
| Lead sponsor | University of Chicago, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Drug |
| Interventions | oxaliplatin, paclitaxel |
| Enrollment | 38 |
| Start date | Nov 1, 1999 |
| Primary completion | Jan 1, 2001 |
| Completion | Aug 1, 2003 |
| First posted | May 21, 2004 |
| Last update posted | Feb 11, 2013 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: